Levit Nudi of Kenya, a self-taught software developer, senior research scientist at Notonlab and instructor at the Africa Digital Media Institute, created the mobile app Tambua to thwart the use of counterfeit and substandard prescription medications, a prevalent issue in Africa.
Philippa Ngaju Makobore of Uganda is an electrical engineer and Department Head of the Instrumentation Division at the Uganda Industrial Research Institute. Philippa and a team of engineers designed the Electronically Controlled Gravity Feed (ECGF) Infusion Set, a prototype medical device that helps to safely and accurately regulate lifesaving IV fluids and drugs in low-resource settings in Uganda. This device drastically improves medical care for children throughout sub-Saharan Africa.
Dr. Askwar Hilonga of Tanzania, a chemical engineer and lecturer at the Nelson Mandela African Institution of Science and Technology, is the inventor of Nanofilter, a low-cost customized water filtration system designed to clean contaminated water in rural areas of Tanzania.
Maame Ekua Manful of Ghana, an academic research student from Kwame Nkrumah University of Science and Technology, combined her passion for cooking and science into an entrepreneurial venture. Her budding start-up Sweetpot Yoghurt produces a sweet potato-flavored, fortified yogurt that addresses the issue of vitamin A deficiency syndrome, a problem prevalent in developing countries in Africa.
During a special session at the American Association for the Advancement of Science Annual Meeting, Johnson & Johnson hosted an award celebration and panel discussion to spotlight the winners of the Champions of Science®—Africa Storytelling Challenge and discuss the importance of engaging more champions of science across the world.
During a special session at the American Association for the Advancement of Science Annual Meeting, Johnson & Johnson hosted an award celebration and panel discussion to spotlight the winners of the Champions of Science®—Africa Storytelling Challenge and discuss the importance of engaging more champions of science across the world.
During a special session at the American Association for the Advancement of Science Annual Meeting, Johnson & Johnson hosted an award celebration and panel discussion to spotlight the winners of the Champions of Science®—Africa Storytelling Challenge, hear from esteemed African leaders about the exciting science and technology developments taking place across the continent, and facilitate a discussion about the importance of engaging more champions of science across the world.
If we could penetrate the blood-brain barrier, gaining VIP access to these brain blood vessel walls, then we could safely diagnose more neurodegenerative diseases and brain disorders and save more lives.
If we could develop innovative technology such as a personal sensor to track the amount of carbon monoxide in a smoker's lungs, then this and other types of interventions could help change the behaviors around smoking and potentially save lives.
As part of the Johnson & Johnson Art of Ending Stigma initiative, original artwork was featured during the 2019 World Economic Forum in Davos, Switzerland.
I have the privilege of being the CEO of Johnson & Johnson during a remarkable time in history. Throughout my seven years in this role, there have been many dramatic changes in global politics, the world economy, science, technology and culture. At the same time, there has also been an accelerated pace of progress in human health: unlocking the possibilities of the human genome, evolving and expanding the use of robotics and micro surgery, extending the life expectancy for people with HIV, and continuing to wage and win the fight against cancer and other debilitating diseases that have resisted treatment for generations.
Johnson & Johnson is a committed partner in the global fight against tuberculosis (TB) and is dedicated to ensuring that bedaquiline, our multidrug-resistant TB (MDR-TB) medicine, reaches patients around the world. To date, Johnson & Johnson has shipped more than 84,000 courses of bedaquiline for patients in need in 114 countries, including all MDR-TB high-burden countries.
Consumers deserve a clearer picture of what they can expect to pay at the pharmacy. At Janssen, we have long been a leader in transparency. When the current Administration’s American Patients First Blueprint issued in May of last year proposed including list price information in direct-to-consumer TV ads, we saw an opportunity to envision – and implement – additional transparency that would enable patients to make more informed decisions.